This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Healthcare/Medical Simulation Market - By Product (Patient Simulator, Surgical Simulator, Imaging Simulation, Task Trainer), Technology (Haptic, Virtual Reality), End-Users (Academics, Hospitals, Military) & Services- Trends & Global Forecasts To 2017

NEW YORK, June 18, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Healthcare/Medical Simulation Market – By Product (Patient Simulator, Surgical Simulator, Imaging Simulation, Task Trainer), Technology (Haptic, Virtual Reality), End-Users (Academics, Hospitals, Military) & Services– Trends & Global Forecasts To 2017 http://www.reportlinker.com/p01361105/Healthcare/Medical-Simulation-Market-–-By-Product-Patient-Simulator-Surgical-Simulator-Imaging-Simulation-Task-Trainer-Technology-Haptic-Virtual-Reality-End-Users-Academics-Hospitals-Military--Services–-Trends--Global-Forecasts-To-2017.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Footwear

Fueled by the growing focus on patient safety and technological advancements, the healthcare/medical simulation industry has experienced significant growth over the past decade, except for the past 3 to 4 years, where the market witnessed slow growth due to the global recession. A pivotal factor in the growth of this market has been high fidelity mannequins/patient simulators, which have witnessed substantial growth in recent years owing primarily to recent technological advancements that have created highly realistic simulators competent of very high levels of fidelity. Increasing healthcare costs, rising demand for minimally invasive treatment, and increasing consolidation of manufacturers further propels the market. However, the high cost of simulators, economic slowdown in the developed region, and limited availability of funds inhibits the growth of the market, to a certain extent.

The global healthcare/medical simulation market is broadly segmented into products and services. The market was valued at $790.1 million in 2012 and is poised to grow at a CAGR of 19.6% in the forecast period to reach $1930.5 million by 2017.

North America is the largest market for healthcare/medical simulation, with the U.S. contributing a major share, followed by Europe, and Asia. The Asian market, especially India and China, is expected to witness a boost in demand for medical simulation products and services and is poised to register maximum growth over the next five years, as a result of its economic development.

Prominent players in this market are Laerdal Medical ( Norway), CAE Healthcare ( Canada), Simulaids (U.S.), Gaumard (U.S.), Kyoto Kagako ( Japan), Limbs and Things (U.K.), Education Management Solutions (U.S.), and Mentice AB ( Sweden).

Scope of the report:

This research report largely categorizes the global market for healthcare/medical simulation into products and services. This market is broken down into segments and sub-segments, providing exhaustive value analysis for 2010, 2011 and 2012, as well as forecast up to 2017. The market is also evaluated by end-users and comprehensively analyzed at a granular level by region ( North America, Europe, Asia, and Rest of the World (RoW).

Global Healthcare/medical simulation Products & Services Market

• High Fidelity Mannequin/ Patient Simulators• Simulated Clinical Environments- Live environments- Virtual environmentsSecond lifeSerious games • Interventional simulation- Surgical simulators- Cardiovascular simulators- IV simulators- Endovascular simulators- Ultrasound simulators • Mid / Low Fidelity Task Trainers• Imaging Simulation- Ultrasound Imaging- Magnetic Resonance Imaging (MRI)- Computed Tomography (CT)- Positron Emission Tomography (PET) • Performance Recording• Healthcare/medical simulation training services

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,943.81 +28.74 0.17%
S&P 500 1,967.57 +2.89 0.15%
NASDAQ 4,415.49 +19.2860 0.44%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs